After facing scrutiny last spring, new research suggests that using cannabis to help treat and prevent COVID-19 isn’t so far-fetched after all. Researchers at the University...
Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA) (Nasdaq: APHA), a leading global cannabis company, will release financial results for its first quarter and three-months ended August...
Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced that its subsidiary, ASG Pharma Ltd. (“ASG“), has received its European Union Good...
Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today reported its results for the second quarter ended November 30, 2019. All amounts are expressed in...
Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) announced that its subsidiary Aphria Diamond secured a credit facility, on November 29 2019, with a major Canadian...
Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced it has received a cultivation licence from Health Canada for Aphria Diamond, the Company’s...